E 64

Author：

ISSN： 1174-5886

Source： Drugs in R&D, Vol.3, Iss.2, 2002-02, pp. : 104-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peptide Targeted Copper-64 Radiopharmaceuticals

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 5, 2011-03 ,pp. : 500-520

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular imaging with copper-64 in the drug discovery and development arena

By Smith Suzanne V

Expert Opinion on Drug Discovery, Vol. 2, Iss. 5, 2007-05 ,pp. : 659-672

Informa Healthcare

Access to resources Recommend Favorite

Fc&ggr; Receptor 1 (CD64), a Target Beyond Cancer

Current Pharmaceutical Design, Vol. 15, Iss. 23, 2009-08 ,pp. : 2712-2718

Bentham Science Publishers

Access to resources Recommend Favorite

Eicosanoid inhibitors enhance synergistically the effect of transforming growth factor 1 on CCL 64 cell proliferation

By Kozubik A. Hofmanova J. Dusek L.

European Journal of Pharmacology, Vol. 316, Iss. 2, 1996-12 ,pp. : 349-357

Elsevier

Access to resources Recommend Favorite

CB-64D and CB-184: ligands with high 2 receptor affinity and subtype selectivity

By Bowen W.D. Bertha C.M. Vilner B.J. Rice K.C.

European Journal of Pharmacology, Vol. 278, Iss. 3, 1995-05 ,pp. : 257-260

Elsevier

Access to resources Recommend Favorite